NASDAQ · Healthcare · Biotechnology
BridgeBio Pharma, Inc.
BBIO
BridgeBio Pharma, Inc. CEO Neil Kumar · Market cap $12.7B.
$64.63
-0.05 · -0.08%
52w hi $84.9452w lo $31.77
48
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
4
4 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
9 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Nov 18 | Andrew Lo | Sell | 30,993 | $66.05 | −$2.05M | 32 | |
| Nov 18 | Andrew Lo | Sell | 24,007 | $65.23 | −$1.57M | 28 | |
| Nov 17 | Andrew Lo | Sell | 36,801 | $66.63 | −$2.45M | 35 | |
| Nov 12 | Hannah Valantine | Sell | 25,484 | $66.07 | −$1.68M | 35 | |
| Nov 06 | DANIELS RONALD J | Sell | 61,031 | $63.72 | −$3.89M | 35 | |
| Sep 05 | Frank Mccormick | Sell | 74,000 | $53.16 | −$3.93M | 32 | |
| Jun 27 | VIKING GLOBAL INVESTORS LP | Sell | 3,500,000 | $44.00 | −$154.00M | 35 | |
| May 12 | KKR Genetic Disorder L.P. | Sell | 6,000,000 | $34.20 | −$205.20M | 39 | |
| May 02 | Andrew Lo | Sell | 100,000 | $38.50 | −$3.85M | 32 |
Section 02
Recent STOCK Act disclosures
4 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| May 11 | Gilbert Cisneros | House · CA | Buy | $1,001 - $15,000 | $8K | 12 d | 48 |
| Apr 08 | Gilbert Cisneros | House · CA | Buy | $1,001 - $15,000 | $8K | 20 d | 44 |
| Apr 08 | Gilbert Cisneros | House · CA | Buy | $1,001 - $15,000 | $8K | 21 d | 44 |
| Apr 08 | Gilbert Cisneros | House · CA | Buy | $1,001 - $15,000 | $8K | 36 d | 40 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay